Jenburkt Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Jenburkt Pharma	Albert David	Medico Remedies
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.29 %	0.84 %	n/a
Financials
5 yr Average ROE	18.49 %	11.47 %	13.93 %
5yr average Equity Multiplier	1.17	1.63	2.07
5yr Average Asset Turnover Ratio	0.88	0.62	1.49
5yr Avg Net Profit Margin	18.1 %	11.31 %	4.73 %
Price to Book	2.57	1.11	6.49
P/E	14.25	0.0	38.29
5yr Avg Cash Conversion Cycle	-32.02 Days	-77.77 Days	53.33 Days
Inventory Days	24.72 Days	47.91 Days	48.95 Days
Days Receivable	48.38 Days	27.87 Days	129.15 Days
Days Payable	82.6 Days	140.35 Days	124.28 Days
5yr Average Interest Coverage Ratio	87.2	93.73	11.55
5yr Avg ROCE	24.44 %	14.69 %	20.03 %
5yr Avg Operating Profit Margin	22.46 %	9.55 %	7.11 %
5 yr average Debt to Equity	0.02	0.02	0.26
5yr CAGR Net Profit	14.21 %	-4.92 %	31.26 %
5yr Average Return on Assets	15.8 %	7.03 %	6.88 %
Shareholdings
Promoter Holding	46.66 %	62.24 %	61.38 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.93 %	0.25 %	-11.96 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Jenburkt Pharma	Albert David	Medico Remedies
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Dermatology 0 Traded Goods 0 Manufactured Goods 0	Product Wise Break-Up Pharmaceutical 0 Traded Goods 0 Manufactured Goods 0 Dermatology 0 Others 100	Product Wise Break-Up Pharmaceutical 0 Traded Goods 1.96 Manufactured Goods 96.53 Dermatology 0 Others 1.51
Location Wise Break-Up	Location Wise Break-Up India 87.23 Rest of the World 12.56 Outside India 0 Others 0.21	Location Wise Break-Up Outside India 0 India 93.24 Rest of the World 6.76	Location Wise Break-Up Outside India 89.6 India 10.4 Rest of the World 0